isradipine has been researched along with Hydronephrosis in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Hydronephrosis: Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takenaka, T | 1 |
| Epstein, M | 1 |
| Forster, H | 1 |
| Landry, DW | 1 |
| Iijima, K | 1 |
| Goligorsky, MS | 1 |
1 other study available for isradipine and Hydronephrosis
| Article | Year |
|---|---|
Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid.
Topics: Animals; Antihypertensive Agents; Arterioles; Calcium; Cells, Cultured; Chloride Channels; Dihydropy | 1992 |